Cargando…
Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine
INTRODUCTION: Oxcarbazepine is a carbamazepine pre-drug with less drug interactions. Its adverse effects, including hyponatremia, somnolence and ataxia, are dose dependent. Olanzapine is an atypical antipsychotic drug most commonly used to manage psychoses and symptoms of irritability and aggressive...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195034/ https://www.ncbi.nlm.nih.gov/pubmed/30515002 http://dx.doi.org/10.5455/medarh.2018.72.303-305 |
_version_ | 1783364336609132544 |
---|---|
author | Kalogera, Vasiliki Galopoulos, Dimitrios Eleftheriotis, Gerasimos Meimeti, Evangelia Malios, Ioannis Marathonitis, Georgios Loupa, Chariclia |
author_facet | Kalogera, Vasiliki Galopoulos, Dimitrios Eleftheriotis, Gerasimos Meimeti, Evangelia Malios, Ioannis Marathonitis, Georgios Loupa, Chariclia |
author_sort | Kalogera, Vasiliki |
collection | PubMed |
description | INTRODUCTION: Oxcarbazepine is a carbamazepine pre-drug with less drug interactions. Its adverse effects, including hyponatremia, somnolence and ataxia, are dose dependent. Olanzapine is an atypical antipsychotic drug most commonly used to manage psychoses and symptoms of irritability and aggressive behavior. Main side effects include extrapyramidal and anticholinergic symptoms, weight gain, and hyperglycemia. CASE REPORT: In this manuscript a case of oxcarbazepine and olanzapine intoxication is discussed. A 45-year-old woman, previously diagnosed with bipolar disorder and chronic alcoholism, was presented two hours after ingestion of 30,000mg of oxcarbazepine and 140 mg of olanzapine, combined with alcohol. She was immediately treated with gastric lavage and administration of activated charcoal. During her hospitalization she was hemodynamically and respiratory stable with no neurological signs and symptoms except for somnolence. Another side effect was hyponatremia. She was discharged from our department in stable clinical condition after being evaluated by a psychiatrist. CONCLUSION: Early approach is crucial for the management of drug intoxication. Late symptoms can be avoided through close monitoring of vital signs, mental status and laboratory values. Psychiatric consultation is essential for a better long-term outcome. |
format | Online Article Text |
id | pubmed-6195034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Academy of Medical Sciences of Bosnia and Herzegovina |
record_format | MEDLINE/PubMed |
spelling | pubmed-61950342018-12-04 Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine Kalogera, Vasiliki Galopoulos, Dimitrios Eleftheriotis, Gerasimos Meimeti, Evangelia Malios, Ioannis Marathonitis, Georgios Loupa, Chariclia Med Arch Case Report INTRODUCTION: Oxcarbazepine is a carbamazepine pre-drug with less drug interactions. Its adverse effects, including hyponatremia, somnolence and ataxia, are dose dependent. Olanzapine is an atypical antipsychotic drug most commonly used to manage psychoses and symptoms of irritability and aggressive behavior. Main side effects include extrapyramidal and anticholinergic symptoms, weight gain, and hyperglycemia. CASE REPORT: In this manuscript a case of oxcarbazepine and olanzapine intoxication is discussed. A 45-year-old woman, previously diagnosed with bipolar disorder and chronic alcoholism, was presented two hours after ingestion of 30,000mg of oxcarbazepine and 140 mg of olanzapine, combined with alcohol. She was immediately treated with gastric lavage and administration of activated charcoal. During her hospitalization she was hemodynamically and respiratory stable with no neurological signs and symptoms except for somnolence. Another side effect was hyponatremia. She was discharged from our department in stable clinical condition after being evaluated by a psychiatrist. CONCLUSION: Early approach is crucial for the management of drug intoxication. Late symptoms can be avoided through close monitoring of vital signs, mental status and laboratory values. Psychiatric consultation is essential for a better long-term outcome. Academy of Medical Sciences of Bosnia and Herzegovina 2018-10 /pmc/articles/PMC6195034/ /pubmed/30515002 http://dx.doi.org/10.5455/medarh.2018.72.303-305 Text en © 2018 Vasiliki Kalogera, Dimitrios Galopoulos, Gerasimos Eleftheriotis, Evangelia Meimeti, Ioannis Malios, Georgios Marathonitis, Chariclia Loupa http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Kalogera, Vasiliki Galopoulos, Dimitrios Eleftheriotis, Gerasimos Meimeti, Evangelia Malios, Ioannis Marathonitis, Georgios Loupa, Chariclia Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine |
title | Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine |
title_full | Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine |
title_fullStr | Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine |
title_full_unstemmed | Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine |
title_short | Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine |
title_sort | patient survival after acute voluntary poisoning with a huge dose of oxcarbazepine and olanzapine |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195034/ https://www.ncbi.nlm.nih.gov/pubmed/30515002 http://dx.doi.org/10.5455/medarh.2018.72.303-305 |
work_keys_str_mv | AT kalogeravasiliki patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine AT galopoulosdimitrios patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine AT eleftheriotisgerasimos patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine AT meimetievangelia patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine AT maliosioannis patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine AT marathonitisgeorgios patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine AT loupachariclia patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine |